Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease.
第一作者:
Y,Mazor
第一单位:
Gastroenterology Department, Rambam Health Care Campus, Haifa, Israel; Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
作者:
主题词
成年人(Adult);消炎药(Anti-Inflammatory Agents);抗体(Antibodies);C反应蛋白质(C-Reactive Protein);Crohn病(Crohn Disease);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);ROC曲线(ROC Curve);回归分析(Regression Analysis);敏感性与特异性(Sensitivity and Specificity);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1111/apt.12869
PMID
25039584
发布时间
2022-04-08
- 浏览24
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文